Literature DB >> 19276088

Epitope-tagged receptor knock-in mice reveal that differential desensitization of alpha2-adrenergic responses is because of ligand-selective internalization.

Roujian Lu1, Yong Li, Youwen Zhang, Yunjia Chen, Angela D Shields, Danny G Winder, Timothy Angelotti, Kai Jiao, Lee E Limbird, Yi Zhou, Qin Wang.   

Abstract

Although ligand-selective regulation of G protein-coupled receptor-mediated signaling and trafficking are well documented, little is known about whether ligand-selective effects occur on endogenous receptors or whether such effects modify the signaling response in physiologically relevant cells. Using a gene targeting approach, we generated a knock-in mouse line, in which N-terminal hemagglutinin epitope-tagged alpha(2A)-adrenergic receptor (AR) expression was driven by the endogenous mouse alpha(2A)AR gene locus. Exploiting this mouse line, we evaluated alpha(2A)AR trafficking and alpha(2A)AR-mediated inhibition of Ca(2+) currents in native sympathetic neurons in response to clonidine and guanfacine, two drugs used for treatment of hypertension, attention deficit and hyperactivity disorder, and enhancement of analgesia through actions on the alpha(2A)AR subtype. We discovered a more rapid desensitization of Ca(2+) current suppression by clonidine than guanfacine, which paralleled a more marked receptor phosphorylation and endocytosis of alpha(2A)AR evoked by clonidine than by guanfacine. Clonidine-induced alpha(2A)AR desensitization, but not receptor phosphorylation, was attenuated by blockade of endocytosis with concanavalin A, indicating a critical role for internalization of alpha(2A)AR in desensitization to this ligand. Our data on endogenous receptor-mediated signaling and trafficking in native cells reveal not only differential regulation of G protein-coupled receptor endocytosis by different ligands, but also a differential contribution of receptor endocytosis to signaling desensitization. Taken together, our data suggest that these HA-alpha(2A)AR knock-in mice will serve as an important model in developing ligands to favor endocytosis or nonendocytosis of receptors, depending on the target cell and pathophysiology being addressed.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19276088      PMCID: PMC2676055          DOI: 10.1074/jbc.M807535200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  78 in total

1.  Functional dissociation of mu opioid receptor signaling and endocytosis: implications for the biology of opiate tolerance and addiction.

Authors:  J L Whistler; H H Chuang; P Chu; L Y Jan; M von Zastrow
Journal:  Neuron       Date:  1999-08       Impact factor: 17.173

2.  Substitution of a mutant alpha2a-adrenergic receptor via "hit and run" gene targeting reveals the role of this subtype in sedative, analgesic, and anesthetic-sparing responses in vivo.

Authors:  P P Lakhlani; L B MacMillan; T Z Guo; B A McCool; D M Lovinger; M Maze; L E Limbird
Journal:  Proc Natl Acad Sci U S A       Date:  1997-09-02       Impact factor: 11.205

3.  Stimulation of mitogen-activated protein kinase by G protein-coupled alpha(2)-adrenergic receptors does not require agonist-elicited endocytosis.

Authors:  N L Schramm; L E Limbird
Journal:  J Biol Chem       Date:  1999-08-27       Impact factor: 5.157

Review 4.  Gene targeting--homing in on alpha 2-adrenoceptor-subtype function.

Authors:  E MacDonald; B K Kobilka; M Scheinin
Journal:  Trends Pharmacol Sci       Date:  1997-06       Impact factor: 14.819

5.  G protein-coupled receptor kinase mediates desensitization of norepinephrine-induced Ca2+ channel inhibition.

Authors:  M Diverse-Pierluissi; J Inglese; R H Stoffel; R J Lefkowitz; K Dunlap
Journal:  Neuron       Date:  1996-03       Impact factor: 17.173

6.  A cre-transgenic mouse strain for the ubiquitous deletion of loxP-flanked gene segments including deletion in germ cells.

Authors:  F Schwenk; U Baron; K Rajewsky
Journal:  Nucleic Acids Res       Date:  1995-12-25       Impact factor: 16.971

7.  Distribution of mRNA encoding three alpha 2-adrenergic receptor subtypes in the developing mouse embryo suggests a role for the alpha 2A subtype in apoptosis.

Authors:  R X Wang; L E Limbird
Journal:  Mol Pharmacol       Date:  1997-12       Impact factor: 4.436

8.  Central hypotensive effects of the alpha2a-adrenergic receptor subtype.

Authors:  L B MacMillan; L Hein; M S Smith; M T Piascik; L E Limbird
Journal:  Science       Date:  1996-08-09       Impact factor: 47.728

9.  Gene substitution/knockout to delineate the role of alpha 2-adrenoceptor subtypes in mediating central effects of catecholamines and imidazolines.

Authors:  L Hein; L E Limbird; R M Eglen; B K Kobilka
Journal:  Ann N Y Acad Sci       Date:  1999-06-21       Impact factor: 5.691

10.  Receptor endocytosis counteracts the development of opioid tolerance.

Authors:  Thomas Koch; Antje Widera; Katharina Bartzsch; Stefan Schulz; Lars-Ove Brandenburg; Nicole Wundrack; Andrea Beyer; Gisela Grecksch; Volker Höllt
Journal:  Mol Pharmacol       Date:  2004-10-08       Impact factor: 4.436

View more
  21 in total

1.  Enhanced hypotensive, bradycardic, and hypnotic responses to alpha2-adrenergic agonists in spinophilin-null mice are accompanied by increased G protein coupling to the alpha2A-adrenergic receptor.

Authors:  R Lu; Y Chen; C Cottingham; N Peng; K Jiao; L E Limbird; J M Wyss; Q Wang
Journal:  Mol Pharmacol       Date:  2010-04-29       Impact factor: 4.436

2.  Cortical adrenoceptor expression, function and adaptation under conditions of cannabinoid receptor deletion.

Authors:  B A S Reyes; A F Carvalho; P Szot; D J Kalamarides; Q Wang; L G Kirby; E J Van Bockstaele
Journal:  Exp Neurol       Date:  2017-03-21       Impact factor: 5.330

3.  Cellular Heterogeneity of the Luteinizing Hormone Receptor and Its Significance for Cyclic GMP Signaling in Mouse Preovulatory Follicles.

Authors:  Valentina Baena; Corie M Owen; Tracy F Uliasz; Katie M Lowther; Siu-Pok Yee; Mark Terasaki; Jeremy R Egbert; Laurinda A Jaffe
Journal:  Endocrinology       Date:  2020-07-01       Impact factor: 4.736

Review 4.  Are the pharmacology and physiology of α₂ adrenoceptors determined by α₂-heteroreceptors and autoreceptors respectively?

Authors:  Ralf Gilsbach; Lutz Hein
Journal:  Br J Pharmacol       Date:  2012-01       Impact factor: 8.739

5.  In vivo mapping of a GPCR interactome using knockin mice.

Authors:  Jade Degrandmaison; Khaled Abdallah; Véronique Blais; Samuel Génier; Marie-Pier Lalumière; Francis Bergeron; Catherine M Cahill; Jim Boulter; Christine L Lavoie; Jean-Luc Parent; Louis Gendron
Journal:  Proc Natl Acad Sci U S A       Date:  2020-05-26       Impact factor: 11.205

6.  The antidepressant desipramine is an arrestin-biased ligand at the α(2A)-adrenergic receptor driving receptor down-regulation in vitro and in vivo.

Authors:  Christopher Cottingham; Yunjia Chen; Kai Jiao; Qin Wang
Journal:  J Biol Chem       Date:  2011-08-22       Impact factor: 5.157

7.  Cannabinoid modulation of alpha2 adrenergic receptor function in rodent medial prefrontal cortex.

Authors:  Alessandra M Cathel; Beverly A S Reyes; Qin Wang; Jonathan Palma; Kenneth Mackie; Elisabeth J Van Bockstaele; Lynn G Kirby
Journal:  Eur J Neurosci       Date:  2014-08-18       Impact factor: 3.386

8.  Cross-talk from β-adrenergic receptors modulates α2A-adrenergic receptor endocytosis in sympathetic neurons via protein kinase A and spinophilin.

Authors:  Christopher Cottingham; Roujian Lu; Kai Jiao; Qin Wang
Journal:  J Biol Chem       Date:  2013-08-21       Impact factor: 5.157

9.  α(2A)-adrenergic receptors filter parabrachial inputs to the bed nucleus of the stria terminalis.

Authors:  Stephanie A Flavin; Robert T Matthews; Qin Wang; E Chris Muly; Danny G Winder
Journal:  J Neurosci       Date:  2014-07-09       Impact factor: 6.167

10.  Diverse arrestin-recruiting and endocytic profiles of tricyclic antipsychotics acting as direct α2A adrenergic receptor ligands.

Authors:  Christopher Cottingham; Pulin Che; Wei Zhang; Hongxia Wang; Raymond X Wang; Stefanie Percival; Tana Birky; Lufang Zhou; Kai Jiao; Qin Wang
Journal:  Neuropharmacology       Date:  2016-12-09       Impact factor: 5.250

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.